Cell Therapy Market Growth, Demand and Challenges of the Key Industry Players 2028

1
Global Cell Therapy Market Research and Forecast
Report 2023-2028




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Cell Therapy Market Research Report The
latest report by IMARC, titled Cell Therapy
Market Global Industry Trends, Share, Size,
Growth, Opportunity and Forecast 2023-2028 the
global cell therapy market size reached US 11.5
Billion in 2022. Cell therapy (CT) replaces or
repairs damaged tissues and cells by using human
cells as transplants. This technology is used to
develop and apply new techniques to restore
function and heal tissues and organs inflicted by
aging, disease, and damage. The therapy also
improves the immune system of the body to combat
cancer cells. Cell therapy can also be used to
treat numerous autoimmune and infectious
diseases, urinary problems, joint damage, spinal
cord injuries, weakened immune systems, and
neurological disorders. Request Free Sample
Report https//www.imarcgroup.com/cell-therapy-ma
rket/requestsample
4
Report Description and Highlights
Report Description

Global Cell Therapy Market Trends The global
market is majorly driven by the rising incidences
of numerous chronic diseases, including cancer
and cardiovascular disorders. In line with this,
the increasing promotions of clinical trials by
various governing agencies of several countries
are contributing to the growth of the market.
Moreover, the extensive research and development
(RD) activities conducted by key players
regarding stem cell therapy are providing an
impetus to the market. In addition to this, the
introduction of advanced cell-based therapies,
such as direct cell reprogramming for neuronal
tissue replacement, skin rejuvenation and tendon
regeneration therapies, is creating a positive
market outlook. Furthermore, continual
technological advancements in the healthcare
infrastructure are acting as another significant
growth-inducing factor. Some of the other factors
contributing to the market growth include the
escalating demand for regenerative drugs and a
considerable increase in medical expenditure. On
account of the aforementioned factors, the market
is anticipated to reach a value of US 32.1
Billion by 2028, exhibiting a CAGR of 17.5
during 2023-2028. Looking forward, the market
value is projected to reach a strong growth
during the forecast period (2023-2028).
5
Report Description and Highlights
Report Description
Market Summary Breakup by Cell Type
Stem Cell Bone Marrow
Blood Umbilical Cord-Der
ived Adipose-Derived Stem Cell
Others Non-stem Cell B
reakup by Therapy Type Autologous
Allogeneic Breakup by Therapeutic Area
Malignancies Musculoskeletal Disor
ders Autoimmune Disorders

6
Report Description and Highlights
Report Description
Dermatology Others Breakup by
End User Hospitals and Clinics
Academic and Research Institutes
Breakup by Region North America
United States Canada
Asia-Pacific China
Japan India
South Korea Austra
lia Indonesia
Others Europe

7
Report Description and Highlights
Report Description
Germany France
United Kingdom
Italy Spain
Russia Others Latin Am
erica Brazil M
exico Others Middle Ea
st and Africa

8
Report Description and Highlights
Report Description

• Competitive Landscape with Key Players
• AlloSource
• Anterogen Co. Ltd. Cells for Cells Holostem Terap
  ie Avanzate S.r.l. JCR Pharmaceuticals Kolon Tissu
  eGene Inc. MEDIPOST Mesoblast Limited NuVasive Ste
  medica Cell Technologies Inc. Stempeutics Research
  Pvt. Ltd Vericel Corporation
• View Full Report with TOC List of Figure
  https//www.imarcgroup.com/cell-therapy-market

9
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
12

Contact Us